PRVA NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Privia Health Group Inc · Healthcare · Health Information Services

Open interactive chart View report data
Latest close 23.67 USD
-7.2% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 1.2% above the Trend Line and sits at 48.0% of its 52-week range. The latest completed week returned -7.2%, after a -13.5% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is expensive relative to peers. Options positioning is bullish with 48/100 conviction, while the latest news-sentiment score is 51/100. Near-term considerations: volume confirmation is below normal; earnings are due in 5d.

Setup score 34 out of 100
Latest Close 23.67 USD 31 Jul 2026
1W Return -7.2% latest completed week
4W Return -13.5% short-term follow-through
12W Return 2.6% quarterly tape
Trend Breadth 38.5% 20 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • The trend backdrop is active with a 5-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Next-week expectancy is negative at 41.16% based on similar historical setup states.
  • 2 reversal markers appear in the recent smart-money tape.
  • The latest week was a sharp negative move.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -7.2% Latest completed week; four-week move -13.5%. Indicator stack 38/67 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 41.16% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Bullish 48/100 conviction; expected move 15.9%. News sentiment 51/100 61 relevant articles in the latest sentiment read. Event risk 5d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 1.2% above the Trend Line and sits at 48.0% of its 52-week range. The latest completed week returned -7.2%, after a -13.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6212-week average 0.44

12-week confirmation

Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership4/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.62Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -13.5% over four weeks, 2.6% over 12 weeks, and 25.5% over one year. The current trend has remained active for 5 consecutive weeks.

Performance by holding period

1W-7.2%
4W-13.5%
12W2.6%
26W1.9%
52W25.5%
Active trend streak5 weeks
Active weeks in one year20
Trend breadth38.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.95Latest activity-pressure read.
Pressure change-5.2%Four-week change in activity pressure.
Leadership-7.69Latest relative-leadership reading.
RS change-326.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength9/100Blend of value, momentum, and quality. Underlying universe rank 92; rank 1 is best.
Value6/100Relative valuation strength. Underlying universe rank 95; rank 1 is best.
Quality15/100Profitability and accounting quality. Underlying universe rank 86; rank 1 is best.
Momentum76/100Medium-term price momentum. Underlying universe rank 25; rank 1 is best.
Growth75/100Revenue and earnings growth. Underlying universe rank 26; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
147.7x
Price divided by trailing earnings.
Price / sales
1.4x
Market value relative to trailing revenue.
EV / EBITDA
50.6x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
4.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
9.6%
Gross profit retained from each unit of revenue.
Operating margin
2.0%
Operating profit retained from revenue.
Free-cash-flow margin
6.3%
Free cash flow generated from revenue.
Return on invested capital
8.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
24.7%
Latest one-year revenue growth.
EPS growth
39.3%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
13.8%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.2%
Net share repurchases relative to market value.
Shareholder yield
-0.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-7.3x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

PRVA shows bullish options pressure with a 48/100 conviction score, put-call volume ratio of 0.00, expected move of 15.9%, and Sharemaestro trend signal active.

Conviction48/100
Expected move15.9%
Put/call volume0.00
Pressure100
Speculation0
Volatility61
Trend agreement0
Open options detail
Insider activity5 / 15

5 acquisitions and 15 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment51/100

Weighted news tone is neutral across 61 relevant articles.

9 positive · 46 neutral · 6 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings5dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move15.9%Nearest-chain priced movement where available.
52-week drawdown-17.9%Distance below the 52-week high.
13-week volatility5.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+8.3%Week of 12 Jun.
Worst week-7.2%Week of 8 May.
Latest week-7.2%Week of 31 Jul.

Shape of recent returns

Strong gains8
Modest gains4
Flat weeks0
Modest losses7
Sharp losses7
Recent vol5.2%13-week weekly-return volatility.
Base vol4.5%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew3.9% / -3.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape36/100

Trend, activity pressure, participation, and risk combine to a 36/100 tape read.

 Indicator analysis53/100

Latest 12-week confirmation: trend 5/12, activity pressure 12/12, relative leadership 4/12.

Activity pressure 0.62; 2 reversal markers Next-Week ExpectancyNegative 41.16%

Next-week expectancy is negative with a 41.16% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors23/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 73; Small Cap Core rank 96 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options45/100

PRVA shows bullish options pressure with a 48/100 conviction score, put-call volume ratio of 0.00, expected move of 15.9%, and Sharemaestro trend signal active.

Bullish · Call-side pressure · Expected move 15.9% Sentiment51/100

Weighted news tone is neutral across 61 relevant articles.

(PRVA) Movement as an Input in Quant Signal Sets Insiders5 / 15

5 acquisitions and 15 disposals in the latest 180-day insider tape.

 Earnings5d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202623.67 USD-7.2%23.39 USD21.95 USD0.95-7.694.6MOn
24 Jul 202625.50 USD-5.2%23.38 USD21.97 USD1.260.005.2MOn
17 Jul 202626.90 USD-2.1%23.34 USD21.98 USD1.413.947.3MOn
10 Jul 202627.49 USD0.5%23.23 USD21.98 USD1.201.995.5MOn
3 Jul 202627.36 USD7.0%23.14 USD21.97 USD1.003.394.6MOn
26 Jun 202625.57 USD8.0%23.02 USD21.95 USD0.62-2.628.0MOff
19 Jun 202623.67 USD1.0%22.98 USD21.96 USD0.21-14.094.9MOff
12 Jun 202623.43 USD8.3%22.99 USD21.96 USD0.07-13.135.7MOff
5 Jun 202621.63 USD0.6%22.99 USD21.97 USD0.08-18.394.5MOff
29 May 202621.51 USD-5.6%23.05 USD22.01 USD0.35-23.023.4MOff
22 May 202622.79 USD-0.7%23.14 USD22.04 USD0.73-16.713.4MOff
15 May 202622.95 USD-0.5%23.25 USD22.05 USD0.76-15.675.5MOff
8 May 202623.06 USD-7.2%23.33 USD22.06 USD0.64-16.217.1MOff
1 May 202624.85 USD4.2%23.37 USD22.08 USD0.38-5.636.2MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.